Chong Kun Dang Pharmaceutical Corp.;Inje University Industry-Academic Cooperation Foundation
发明人:
申请号：
EP13833207.7
公开号：
EP2890677B1
申请日:
2013.08.29
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention relates to novel N-acylhydrazone derivatives, and more particularly to novel N-acylhydrazone derivatives having selective T cell inhibitory activity and/or anti-lymphoid malignancy activity, stereoisomers thereof, pharmaceutically acceptable salts thereof, the use thereof for preparing pharmaceutical compositions, pharmaceutical compositions containing the same, treatment methods using the compositions, and methods for preparing the novel N-acylhydrazone derivatives.
